| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.51▼ | 8.61▼ | 8.64▼ | 8.46▲ | 9.32▼ |
| MA10 | 8.56▼ | 8.69▼ | 8.78▼ | 8.75▼ | 11.28▼ |
| MA20 | 8.60▼ | 8.78▼ | 8.61▼ | 9.59▼ | 10.46▼ |
| MA50 | 8.67▼ | 8.49▲ | 8.58▼ | 11.55▼ | 8.64▼ |
| MA100 | 8.79▼ | 8.64▼ | 9.10▼ | 10.49▼ | 5.43▲ |
| MA200 | 8.66▼ | 9.19▼ | 10.41▼ | 9.37▼ | 4.07▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | -0.052▼ | -0.013▼ | -0.044▼ | -0.530▼ |
| RSI | 31.695▼ | 38.166▼ | 44.182▼ | 35.860▼ | 44.181▼ |
| STOCH | 6.306▼ | 7.856▼ | 21.970 | 21.581 | 24.878 |
| WILL %R | -89.474▼ | -96.748▼ | -68.391 | -76.860▼ | -90.646▼ |
| CCI | -96.620 | -129.228▼ | -132.155▼ | -50.059 | -88.936 |
|
Tuesday, September 29, 2026 12:05 AM
LOS ANGELES, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “we” or “us” or “IMMX”), a global leader in relapsed/refractory AL Amyloidosis, today announced the ...
|
|
Monday, September 28, 2026 04:59 PM
Detailed price information for Immix Biopharma Inc (IMMX-Q) from The Globe and Mail including charting and trades.
|
|
Monday, September 28, 2026 02:02 PM
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let's take a look at how IMAX (NYSE:IMAX) and the rest ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/10/26 | 8.94 | 9.10 | 8.47 | 8.51 | 1,539,849 |
| 20/10/26 | 8.26 | 9.03 | 8.235 | 8.91 | 1,215,718 |
| 19/10/26 | 8.05 | 8.35 | 8.00 | 8.22 | 1,302,364 |
| 16/10/26 | 8.67 | 8.67 | 7.95 | 7.98 | 1,468,115 |
| 15/10/26 | 8.51 | 8.905 | 8.45 | 8.68 | 1,261,536 |
| 14/10/26 | 8.60 | 8.87 | 8.42 | 8.51 | 1,360,377 |
| 13/10/26 | 9.10 | 9.29 | 8.66 | 8.69 | 1,483,590 |
| 12/10/26 | 9.42 | 9.56 | 9.18 | 9.25 | 936,248 |
| 09/10/26 | 9.29 | 9.53 | 9.18 | 9.46 | 1,109,053 |
| 08/10/26 | 9.34 | 9.37 | 8.96 | 9.29 | 1,288,913 |
|
|
||||
|
|
||||
|
|